NEW YORK, August 9, 2026, 15:01 EDT — U.S. trading has ended for the session.
- Rocket Lab closed on Friday at $82.83, up 27.5% across five sessions.
- Second-quarter revenue is expected to reach $231 million, close to the midpoint of guidance, according to preliminary consensus.
- Rocket Lab’s share price on Friday equates to 0.3260 shares for each Iridium share. This figure is 18.5% under the upper limit set by the merger collar’s maximum ratio.
Rocket Lab faces a tougher bar ahead of Monday’s earnings release. The stock ended Friday’s session at $82.83, up 27.5% for the week. U.S. markets did not trade on Sunday.
Rocket Lab’s market capitalization rose to approximately $50 billion after the change. That figure represents around 54 times the consensus estimate for 2026 revenues. The basic comparison does not take into account Iridium or the financing of the acquisition.
The gains came after two key announcements from the company. On August 4, Rocket Lab secured a $397 million contract from the U.S. Space Force. Just two days after, the company completed its 92nd Electron launch.
The agreement encompasses spacecraft, launch services, and operational support for the mission. Its disclosed value factors in an additional option, and Neutron would handle the satellite launches. Chief Executive Peter Beck stated, “Our vertically integrated, constellation-class satellite capabilities, mission operations, and launch services uniquely position us to deliver innovative solutions.” GlobeNewswire
The sector saw widespread movement:
| Company | Friday close | Friday | Five days | 2026 YTD |
|---|---|---|---|---|
| Rocket Lab | $82.83 | up 9.46% | up 27.53% | up 18.74% |
| Redwire Corporation NYSE:RDW | $13.59 | up 14.88% | up 57.66% | up 78.82% |
| Intuitive Machines NASDAQ:LUNR | $16.40 | up 9.85% | up 32.90% | up 1.05% |
| Firefly Aerospace NASDAQ:FLY | $26.71 | up 11.01% | up 31.38% | up 19.40% |
Results are as of the close on August 7.
Rocket Lab lagged behind peers over the five-day stretch, as all other listed companies posted stronger gains. This makes Monday’s guidance from the company particularly significant.
The earnings backdrop continues to be limited:
| Metric | Q1 2026 actual | Q2 company outlook | Q2 preliminary consensus |
|---|---|---|---|
| Revenue | $200.3 million | $225 million–$240 million | $231 million |
| GAAP gross margin | 38.2% | 33%–35% | — |
| Earnings per share | -$0.07 | — | -$0.08 |
| Backlog | $2.2 billion | — | — |
Company performance and outlook are assessed against initial market expectations.
The current consensus for preliminary revenue is $1.5 million under the midpoint of guidance at $232.5 million. Investors may expect more than just results meeting forecasts following the recent share gains. Attention is set to be focused on backlog, margins, cash flow, and updates on Neutron’s progress.
An additional factor involves the rising value of Rocket Lab’s shares. The proposed takeover of Iridium Communications NASDAQ:IRDM will be conducted using a floating exchange ratio.
Iridium shareholders will receive $27 in cash plus approximately $27 in shares. The exchange ratio is variable as long as Rocket Lab’s reference price stays within the $67.50 to $112.50 range. The transaction is anticipated to close in mid-2027, pending shareholder and regulatory consent.
The collar structure highlights how the rally could prove advantageous:
| Illustrative Rocket Lab reference price | RKLB shares per IRDM share | Compared to maximum share count |
|---|---|---|
| $67.50 lower boundary | 0.4000 | 100.0% |
| $82.83 Friday close, for example | 0.3260 | 81.5% |
| $112.50 upper boundary | 0.2400 | 60.0% |
The precise ratio will be based on a 10-day volume-weighted average price taken just prior to the transaction’s completion. The final ratio is not determined by Friday’s closing price.
The example ratio drops to 0.3260 at Friday’s closing price, representing an 18.5% decrease from the top 0.4000 ratio. The ultimate number of shares is still unknown, as the mandatory reference period is yet to come.
The deal would include Iridium’s $871.7 million in expected 2025 revenue. Iridium reported $495 million in operational EBITDA. Rocket Lab arranged a $3.6 billion bridge facility to finance the acquisition.
Analyst ratings stay favorable, but price targets show significant divergence:
| Research firm | Date | Recommendation action | Price target |
|---|---|---|---|
| Piper Sandler Companies NYSE:PIPR | July 16 | Coverage started with Neutral | $83 |
| KeyBanc, a unit of KeyCorp NYSE:KEY | June 15 | Raised to Overweight | $135 |
| Deutsche Bank ETR:DBK | May 12 | Buy rating reiterated | $120 |
| Morgan Stanley NYSE:MS | January 16 | Lifted to Overweight | $105 |
| Current consensus | August 9 | Buy; 18 analysts | $111.31 |
Estimates span between $64 and $150.
The consensus price target of $111.31 suggests a potential upside of approximately 34.4% from Friday. The $64 to $150 range covers both ends of the Iridium collar. Analysts are factoring in notably different views on execution and financing scenarios.
Monday’s results will be released following the market close. The company’s conference call is scheduled for 5 p.m. EDT. Rocket Lab anticipates conducting another Electron mission before the end of August.
Risks: Delays in Neutron development, launch setbacks, squeezing of margins and timing of contracts may impact outcomes. Additional risks stem from regulatory clearance, funding acquisitions and potential equity dilution.
The main test extends beyond surpassing quarterly expectations. Rocket Lab’s valuation needs backing from guidance, while Iridium should maintain its robust stock currency.
